5,208
Views
149
CrossRef citations to date
0
Altmetric
Research-article

Ecofriendly synthesis of silver and gold nanoparticles by Euphrasia officinalis leaf extract and its biomedical applications

, , &
Pages 1163-1170 | Received 27 Jun 2017, Accepted 27 Jul 2017, Published online: 08 Aug 2017

Figures & data

Figure 1. Schematic procedure of synthesis of silver and gold nanoparticles using Euphrasia officinalis leaf extract.

Figure 1. Schematic procedure of synthesis of silver and gold nanoparticles using Euphrasia officinalis leaf extract.

Figure 2. UV–vis spectra and FE-TEM images of silver nanoparticles (a) and gold nanoparticles (b).

Figure 2. UV–vis spectra and FE-TEM images of silver nanoparticles (a) and gold nanoparticles (b).

Figure 3. Elemental mapping and EDX spectrum of silver nanoparticles (a) and gold nanoparticles (b).

Figure 3. Elemental mapping and EDX spectrum of silver nanoparticles (a) and gold nanoparticles (b).

Figure 4. XRD and SAED pattern of silver nanoparticles (a) and gold nanoparticles (b).

Figure 4. XRD and SAED pattern of silver nanoparticles (a) and gold nanoparticles (b).

Figure 5. DLS and zeta potential result of silver nanoparticles (a) and gold nanoparticles (b).

Figure 5. DLS and zeta potential result of silver nanoparticles (a) and gold nanoparticles (b).

Figure 6. FTIR spectra of Euphrasia officinalis leaf extract, silver nanoparticles and gold nanoparticles.

Figure 6. FTIR spectra of Euphrasia officinalis leaf extract, silver nanoparticles and gold nanoparticles.

Figure 7. Cytotoxic effect of silver nanoparticles (a) and gold nanoparticles (b) against RAW 264.7 macrophages cell line, A549 lung cancer cell line and HeLa cervical cancer cell lines, respectively.

Figure 7. Cytotoxic effect of silver nanoparticles (a) and gold nanoparticles (b) against RAW 264.7 macrophages cell line, A549 lung cancer cell line and HeLa cervical cancer cell lines, respectively.

Figure 8. Zones of inhibition against Pseudomonas aeruginosa [KACC 14021], Escherichia coli [CCARM 0237], Vibrio parahaemolyticus [KACC 15069] and Staphylococcus aureus [KCTC 3881], respectively.

Figure 8. Zones of inhibition against Pseudomonas aeruginosa [KACC 14021], Escherichia coli [CCARM 0237], Vibrio parahaemolyticus [KACC 15069] and Staphylococcus aureus [KCTC 3881], respectively.

Table 1. Antimicrobial activity of the AgNPs synthesized from Euphrasia officinalis leaf extract.

Figure 9. Biofilm inhibition activity of silver nanoparticles against Staphylococcus aureus [KCTC 3881] and Pseudomonas aeruginosa [KACC 14021].

Figure 9. Biofilm inhibition activity of silver nanoparticles against Staphylococcus aureus [KCTC 3881] and Pseudomonas aeruginosa [KACC 14021].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.